Showing 941-950 of 1614 results for "".
- CooperVision DreamLite Ortho-K Lenses Gain European Approval for Slowing Progression of Myopiahttps://modernod.com/news/coopervision-dreamlite-ortho-k-lenses-gain-european-approval-for-slowing-progression-of-myopia/2479240/CooperVision Specialty EyeCare’s Procornea DreamLite night lenses have received European approval for slowing the progression of myopia in children and young adults. The orthokeratology contact lens is the latest CooperVision myopia control product to gain the CE Mark, joining EyeDream and Parago
- Rayner Receives FDA Approval for RayOne Spheric Monofocal IOLhttps://modernod.com/news/rayner-receives-fda-approval-for-rayone-spheric-monofocal-iol/2479221/Rayner has received FDA approval for the RayOne Spheric fully-preloaded monofocal IOL. The approval marks Rayner’s third FDA approval in under 3 years within its RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive
- Johnson & Johnson Vision Announces FDA Approval of Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Managementhttps://modernod.com/news/johnson-johnson-vision-announces-fda-approval-of-acuvue-abiliti-overnight-therapeutic-lenses-for-myopia-management/2479199/Johnson & Johnson Vision Care announced that the FDA has approved Acuvue Abiliti-Overnight Therapeutic Lenses. This is the first and only FDA approved orthokeratology (ortho-k) contact lens for the management of myopia. “The FDA approval of Abiliti Overnight marks an
- J&J’s COVID-19 Vaccine Wins FDA Authorization for Emergency Usehttps://modernod.com/news/jjs-covid-19-vaccine-wins-fda-authorization-for-emergency-use/2478921/The US has added a third option to its arsenal of COVID-19 vaccines after the FDA authorized Johnson & Johnson’s single-dose candidate Ad26.COV2.S for emergency use in people 18 years and older on Saturday. Peter Marks, director of the FDA’s Center for Biologics Evaluation a
- Ophtec: Tiny ID Matrix Code Enables Fast Delivery of Premium IOLshttps://modernod.com/news/ophtec-tiny-id-matrix-code-enables-fast-delivery-of-premium-cataract-iols/2478885/Ophtec announced it has recently integrated a laser marking technology in the production process of its premium cataract IOLs. A micro ID matrix code is imprinted in the IOLs loop junctions by the laser. Using this code, special scanners can identify the IOL
- EyeSouth Partners Expands Network to Include 28 Doctors in Ohio and Kentucky Through Affiliation with Midwest Eye Centerhttps://modernod.com/news/eyesouth-partners-expands-network-to-include-28-doctors-in-ohio-and-kentucky-through-affiliation-with-midwest-eye-center/2478742/EyeSouth Partners has announced that it has completed an affiliation with Midwest Eye Center (MWEC), representing EyeSouth’s first in the states of Ohio and Kentucky. Terms of the deal were not disclosed. Midwest Eye Center is led by Drs. Mark Cepela, Jean Noll, Faiz Khaja, Saif Jaw
- Hoya Surgical Optics Introduces On-Demand Platform Qube Pro Powered by Eyeflexahttps://modernod.com/news/hoya-surgical-optics-introduces-on-demand-platform-qube-pro-powered-by-eyeflexa/2478514/Hoya Surgical Optics obtained CE Mark for “Qube pro powered by eyeflexa,” a technology that can support both cataract and vitreoretinal surgery. Eyeflexa is a multi-upgrade platform designed to evolve with the changing needs of ophthalmic surgeons, according to a company news r
- Bascom Palmer Eye Institute Ranked Nation’s No. 1 in Ophthalmology for 19th Timehttps://modernod.com/news/bascom-palmer-eye-institute-ranked-nations-no-1-in-ophthalmology-for-19th-time/2478089/Bascom Palmer Eye Institute of the University of Miami Health System has been ranked again as the nation’s best in ophthalmology by U.S News & World Report. This year marks the 19th time, and the 17th consecutive year, that
- Lilly Begins World’s First Human Study of Antibody to Treat COVID-19https://modernod.com/news/lilly-begins-worlds-first-human-study-of-antibody-to-treat-covid-19/2477853/Eli Lilly said that the first patients have been dosed in a phase 1 trial investigating the experimental antibody LY-CoV555 for the treatment of COVID-19. The company, which is developing the drug with partner AbCellera, noted that the move marks the world’s first study of a potential antib
- Santen Receives Canadian Drug Expert Committee Reimbursement Recommendation for Verkazia Eye Dropshttps://modernod.com/news/santen-receives-canadian-drug-expert-committee-reimbursement-recommendation-for-verkazia-eye-drops/2477114/Santen Canada announced that the Canadian Agency for Drugs and Technologies in Health (CADTH) Canadian Drug Expert Committee (CDEC) released a reimbursement recommendation for Verkazia (cyclosporine 0.1%) eye drops. This reimbursement recommendation marks an important step towards providin